LISA tri 839MP HEN 301-11

About this trial

Last updated 7 years ago

Study ID

Status

Completed

Type

Interventional

Phase

N/A

Placebo

Accepting

50 to 80 Years

All

Trial Timing

Ended 10 years ago

The purpose of this study is to compare the performances of 2 bifocal IOLs and 1 trifocal IOL for far, near and intermediate vision.

Inclusion Criteria

- Patients of any gender, aged 50 to 80 years

- Signed informed consent form

- Healthy eyes besides cataract

- Assured follow-up examinations

- Stable corneal conditions within the last 12 months

- Corneal astigmatism less than 1D

- Implantation into the capsular bag by injector

Exclusion Criteria

- Degenerative visual disorders (e.g. macular degeneration, optic nerve atrophy, or retinal disorders)

- Pseudophakia

- Cornea guttata; keratoplasty

- Irregular astigmatism (e.g. Keratoconus)

- Corneal scarring

- Diabetic retinopathy

- Aniridia

- Amblyopia

- Amotio operation; anamnesis with vitreous surgery

- Pseudoexfoliation Syndrome; Uveitis

- Previous intraocular and corneal surgery

- Intraocular tumours; endotamponade

- Glaucoma or IOP higher than 24mmHg

- Phlogistic intraocular processes or other pre-existing processes that permanently limit the best corrected visual acuity to > 0.3 logMAR

- Need for a dioptre out of the range of +16.0D to +26.0D

- Inability to achieve secure lens placement in the capsular bag

- Any other pathology or condition presenting, according to the investigator opinion, a risk for the patient

- Intraoperative complications, damaged posterior bag, intraocular haemorrhage, can opener rhexis

- Pregnancy or lactation period for female patients

Clinical Study to Evaluate the Visual Performance of Three Multifocal IOLs